Navigation Links
Come Visit Visikol at AACR in Atlanta at Booth #3252
Date:3/19/2019

The AACR annual conference pulls together a diverse group of clinical and laboratory researchers and is a great opportunity to see the most cutting-edge cancer research. The Visikol team will be at the show at booth #3252 and will be highlighting their work with 3D cell culture assays as well as their digital pathology services. “For AACR this year we are highlighting specifically our immuno-oncology focused services as this is an area in which we assisted many of our Clients this past year. The combination of our advanced imaging tools with our 3Screen™ image analysis software and 3D in vitro assay services has allowed us to address complex research questions in this space that are challenging to address with traditional techniques,” explained Visikol CSO Dr. Thomas Villani.

In 2018, Visikol launched its immune cell infiltration assay which leverages 3D tumor spheroids as well as Visikol’s proprietary imaging technologies to provide a medium-throughput in vitro assay to assess pharmacokinetics in highly relevant in vitro models. Additionally, Visikol has developed several digital pathology tools for quantifying cancer specific endpoints from H&E and IHC slides such as tumor area or T cell penetration depth. “We are working closely with our Clients to extract not only more data from tissues and 3D cell culture models, but also to transform this data into meaningful insights that can be used in clinical studies to stratify patients for treatment or in earlier studies to quantitatively assess efficacy,” described Visikol Director of Imaging Dr. Graeme Gardner.

To discuss your next in vitro or pathology project with Visikol, stop by and connect with the team at booth 3252.

About Visikol
Visikol is a CRO focused on advanced drug discovery that is leading the field of bio-imaging, bioinformatics and image analysis. We conduct end-to-end drug discovery services that include both 2D and 3D in vitro models and assays, 3D whole mount tissue imaging, digital pathology and custom drug discovery projects. Visikol offers a portfolio of drug discovery services ranging from 2D and 3D cell culture model and assay development to in vitro screening, animal tissue histology and automated image processing. The focus of these services is to transform tissues into images and ultimately into quantitative data sets that can be mined for actionable insights that help our Clients make more informed decisions during the drug discovery process. Additionally, Visikol manufactures and sells a suite of tissue clearing reagents and 3D immuno-labeling kits. These products allow researchers to easily and rapidly image whole tissues and 3D cell culture models in 3D instead of traditional 2D sectioning. For more information about Visikol or its services, please visit our website at visikol.com.

Read the full story at https://www.prweb.com/releases/come_visit_visikol_at_aacr_in_atlanta_at_booth_3252/prweb16173776.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology technology :

1. Visit Rick McCleary & Mike Lindenmuth of Avomeen on September 14th at the 16th Annual Contract Pharma Show.
2. Searching for Bold Innovation from a Trusted Source? Visit MEDITECH at HIMSS17
3. AxioMed Continues International Push with Visit to German Surgeons to Discuss Viscoelastic Total Disc Replacement Technology
4. AxioMed Expanding International Presence with Visit to Swiss Surgeons
5. Representative Scott Peters Visits Avelas Biosciences
6. Dr. Peter Schultz, CEO of The Scripps Research Institute, Visits WuXi AppTec Headquarters in Shanghai
7. William Pate, a Former Chief Marketing Officer of BellSouth and Current CEO of Atlanta Convention and Visitors Bureau, Joins PogoTec™ Board of Directors
8. Emergency Department Visits For Heart Attacks Decline 24 Percent
9. U.S.-Russian Innovation Corridor Program Connects Visiting Russian Startups to U.S. Experts
10. Visit the New Tampa Chiropractor, Dr. Christine Rogers, at Elan Wellness Center of Tampa That's Providing Real Relief from All Types of Physically Related Pain
11. Omnia Education Expects Record Turnout for the 10th Annual Women's Health Annual Visit and Stages in Women's Health Capstone Medical Education Conference in New York City
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/8/2019)... Utah and BOSTON (PRWEB) , ... April 08, ... ... delivering cloud-based enterprise-class unified communications and collaboration solutions, announced today the launch of ... integration to an unprecedented range of business and contact-orientated applications while using CT ...
(Date:4/8/2019)... (PRWEB) , ... April 09, 2019 , ... ... disease, the innovative non-profit research center Chan Zuckerberg Biohub (CZ Biohub) has chosen ... of antibody repertoires is part of CZ Biohub’s efforts to establish new approaches ...
(Date:4/4/2019)... (PRWEB) , ... April 03, 2019 , ... ... together through intimate off-the-record collaboration and dialogue, today announces its Boston CEO conference ... offers insights into the industry’s challenges and opportunities with high-level panels and discussions ...
(Date:3/27/2019)... ... ... A leader in the field of Regenerative Veterinary Medicine, VetStem Biopharma has ... Canada since 2004. The primary indications for VetStem Regenerative Cell Therapy are ... and horse. Recently, VetStem teamed up with the world-renowned San Diego Zoo to ...
Breaking Biology Technology:
(Date:4/4/2019)... ... April 02, 2019 , ... Researchers from Ambry Genetics ... RNA genetic testing (RGT), as a supplement to DNA genetic testing, improves variant ... poster, is one of 13 presentations at the 2019 American College of Medical ...
(Date:4/1/2019)... ... April 01, 2019 , ... ... Characterizing Skin Related Conditions” by the US Patent and Trademark Office on January ... an invention by uBiome collaborators Dr. Zachary Apte, Dr. Daniel Almonacid, Dr. ...
(Date:3/29/2019)... ... ... In the development of biosimilars, the broad definition of the similarity concept in ... several manufacturers have been successful and numerous follow-on biologics are approved in the US ... analytical similarity is achieved in biosimilars based on recently approved products in the US. ...
Breaking Biology News(10 mins):